CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade AstraZeneca PLC - SEK - AZNs CFD

    1328.0
    0.3%
    4.5
    Low: 1325
    High: 1335.5
    Market Trading Hours* (UTC) Opens on Monday at 08:00

    Mon - Fri: 08:00 - 16:25

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 4.5
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021947 %
    Charges from full value of position ($-4.17)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021947%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000275 %
    Charges from full value of position ($-0.05)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000275%
    Overnight fee time 22:00 (UTC)
    Min traded quantity 1
    Currency SEK
    Margin 5%
    Stock exchange Sweden
    Commission on trade 0%

    *Information provided by Capital.com

    AstraZeneca PLC ESG Risk Ratings

    High Medium Low Negligible

    ‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

    More ESG coverage

    Key Stats
    Prev. Close* 1324
    Open* 1328.5
    1-Year Change* -6.73%
    Day's Range* 1325 - 1335.5
    52 wk Range 100.12-123.92
    Average Volume (10 days) 1.31M
    Average Volume (3 months) 34.89M
    Market Cap 156.89B
    P/E Ratio 33.46
    Shares Outstanding 1.55B
    Revenue 36.02B
    EPS 3.03
    Dividend (Yield %) 2.326
    Beta 0.29
    Next Earnings Date Feb 8, 2024

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Dec 8, 2023 1328.0 8.0 0.61% 1320.0 1337.0 1318.0
    Dec 7, 2023 1324.0 0.0 0.00% 1324.0 1341.5 1316.0
    Dec 6, 2023 1339.0 -9.0 -0.67% 1348.0 1356.5 1338.0
    Dec 5, 2023 1346.0 -8.5 -0.63% 1354.5 1357.0 1335.0
    Dec 4, 2023 1356.0 14.0 1.04% 1342.0 1358.0 1337.0
    Dec 1, 2023 1348.5 3.5 0.26% 1345.0 1365.4 1341.5
    Nov 30, 2023 1341.5 21.0 1.59% 1320.5 1346.0 1316.0
    Nov 29, 2023 1324.0 19.5 1.49% 1304.5 1334.0 1303.0
    Nov 28, 2023 1308.0 -15.0 -1.13% 1323.0 1324.0 1307.0
    Nov 27, 2023 1328.0 -10.5 -0.78% 1338.5 1350.5 1325.5
    Nov 24, 2023 1348.5 3.0 0.22% 1345.5 1353.5 1342.5
    Nov 23, 2023 1348.0 31.5 2.39% 1316.5 1348.5 1316.5
    Nov 22, 2023 1331.5 -11.5 -0.86% 1343.0 1346.5 1330.0
    Nov 21, 2023 1334.5 11.5 0.87% 1323.0 1336.5 1323.0
    Nov 20, 2023 1328.0 -12.0 -0.90% 1340.0 1340.0 1318.5
    Nov 17, 2023 1350.0 -5.0 -0.37% 1355.0 1364.4 1345.0
    Nov 16, 2023 1346.5 19.0 1.43% 1327.5 1347.0 1326.0
    Nov 15, 2023 1332.5 -31.9 -2.34% 1364.4 1368.9 1330.5
    Nov 14, 2023 1365.9 -12.5 -0.91% 1378.4 1383.4 1362.9
    Nov 13, 2023 1371.4 3.5 0.26% 1367.9 1387.9 1361.0

    AstraZeneca PLC - SEK Events

    Time (UTC) Country Event
    No events scheduled
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 44351 37417 26617 24384 22090
    Revenue 44351 37417 26617 24384 22090
    Cost of Revenue, Total 8649 9542 5270 4824 4246
    Gross Profit 35702 27875 21347 19560 17844
    Total Operating Expense 40594 36361 21455 21460 18703
    Selling/General/Admin. Expenses, Total 13512 11519 9338 8964 8479
    Research & Development 9612 8519 6094 5320 5266
    Depreciation / Amortization 4094 3044 1897 1812 1945
    Unusual Expense (Income) 5071 3846 -763 863 -953
    Other Operating Expenses, Total -344 -109 -381 -323 -280
    Operating Income 3757 1056 5162 2924 3387
    Interest Income (Expense), Net Non-Operating -815 -819 -716 -766 -775
    Other, Net -441 -502 -530 -610 -619
    Net Income Before Taxes 2501 -265 3916 1548 1993
    Net Income After Taxes 3293 115 3144 1227 2050
    Minority Interest -5 -3 52 108 105
    Net Income Before Extra. Items 3288 112 3196 1335 2155
    Net Income 3288 112 3196 1335 2155
    Income Available to Common Excl. Extra. Items 3288 112 3196 1335 2155
    Income Available to Common Incl. Extra. Items 3288 112 3196 1335 2155
    Dilution Adjustment 0 0
    Diluted Net Income 3288 112 3196 1335 2155
    Diluted Weighted Average Shares 1560 1427 1313 1301 1267
    Diluted EPS Excluding Extraordinary Items 2.10769 0.07849 2.43412 1.02613 1.70087
    Dividends per Share - Common Stock Primary Issue 2.89361 2.84245 2.83031 2.89446 2.74532
    Diluted Normalized EPS 4.04679 2.22705 1.88804 1.48501 0.85399
    Interest Expense (Income) - Net Operating 0 0
    Total Extraordinary Items
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 11416 10879 11207 10982 10771
    Revenue 11416 10879 11207 10982 10771
    Cost of Revenue, Total 1925 1782 2417 2118 1904
    Gross Profit 9491 9097 8790 8864 8867
    Total Operating Expense 8960 8330 10113 9737 10232
    Selling/General/Admin. Expenses, Total 3592 3196 3469 3353 3340
    Research & Development 2570 2299 2525 2357 2431
    Depreciation / Amortization 952 954 1034 979 983
    Unusual Expense (Income) -285 379 641 1002 1298
    Other Operating Expenses, Total 206 -280 27 -72 276
    Operating Income 2456 2549 1094 1245 539
    Interest Income (Expense), Net Non-Operating -368 -287 -316 -323 -292
    Net Income Before Taxes 2088 2262 778 922 247
    Net Income After Taxes 1820 1804 902 1642 360
    Minority Interest -2 -1 -1 -2 0
    Net Income Before Extra. Items 1818 1803 901 1640 360
    Net Income 1818 1803 901 1640 360
    Income Available to Common Excl. Extra. Items 1818 1803 901 1640 360
    Income Available to Common Incl. Extra. Items 1818 1803 901 1640 360
    Dilution Adjustment
    Diluted Net Income 1818 1803 901 1640 360
    Diluted Weighted Average Shares 1560 1560 1560 1559 1560
    Diluted EPS Excluding Extraordinary Items 1.16538 1.15577 0.57756 1.05196 0.23077
    Dividends per Share - Common Stock Primary Issue 0.91215 0 1.9694 0 0.93017
    Diluted Normalized EPS 1.00614 1.34953 0.90705 0.99743 0.80833
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 22593 26244 19544 15563 15591
    Cash and Short Term Investments 6405 6398 7992 6218 5680
    Cash 1411 1461 1182 755 893
    Cash & Equivalents 4755 4868 6650 4614 3938
    Short Term Investments 239 69 160 849 849
    Total Receivables, Net 9923 8795 5651 5181 4345
    Accounts Receivable - Trade, Net 7508 6324 3956 3813 2995
    Total Inventory 4699 8983 4024 3193 2890
    Prepaid Expenses 1329 1512 1735 865 1436
    Other Current Assets, Total 237 556 142 106 1240
    Total Assets 96483 105363 66729 61377 60651
    Property/Plant/Equipment, Total - Net 9449 10171 8917 8335 7421
    Property/Plant/Equipment, Total - Gross 17192 18495 17110 15852 14639
    Accumulated Depreciation, Total -7743 -8324 -8193 -7517 -7218
    Goodwill, Net 19820 19997 11845 11668 11707
    Intangibles, Net 39307 42387 20947 20833 21959
    Long Term Investments 1142 1237 1147 1459 922
    Note Receivable - Long Term 592 504 325 348 515
    Other Long Term Assets, Total 3580 4823 4004 3171 2536
    Total Current Liabilities 26293 22594 20307 18117 16292
    Accounts Payable 2550 2824 2350 1774 1720
    Accrued Expenses 8303 8079 4994 5085 5148
    Notes Payable/Short Term Debt 261 294 370 154 160
    Current Port. of LT Debt/Capital Leases 5281 1599 2016 1856 1594
    Other Current Liabilities, Total 9898 9798 10577 9248 7670
    Total Liabilities 59446 66095 51107 48250 48183
    Total Long Term Debt 23690 28888 17994 16217 17359
    Long Term Debt 22965 28134 17505 15730 17359
    Capital Lease Obligations 725 754 489 487 0
    Deferred Income Tax 2944 6206 2918 2490 3286
    Minority Interest 21 19 16 1469 1576
    Other Liabilities, Total 6498 8388 9872 9957 9670
    Total Equity 37037 39268 15622 13127 12468
    Common Stock 387 387 328 328 317
    Additional Paid-In Capital 35155 35126 7971 7941 4427
    Retained Earnings (Accumulated Deficit) 1495 3755 7323 4858 7724
    Total Liabilities & Shareholders’ Equity 96483 105363 66729 61377 60651
    Total Common Shares Outstanding 1549.8 1549.4 1312.67 1312.14 1267.04
    Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
    Total Current Assets 22501 22839 22266 22593 20224
    Cash and Short Term Investments 5115 5812 6462 6405 4898
    Cash & Equivalents 4871 5664 6232 6166 4458
    Short Term Investments 244 148 230 239 440
    Total Receivables, Net 11997 11932 10797 11252 10061
    Accounts Receivable - Trade, Net 11300 11092 10289 10521 9336
    Total Inventory 5292 5051 4967 4699 5078
    Other Current Assets, Total 97 44 40 237 187
    Total Assets 96086 96543 96687 96483 94185
    Property/Plant/Equipment, Total - Net 9700 9624 9599 9449 9227
    Goodwill, Net 19939 19960 20001 19820 19707
    Intangibles, Net 37687 38326 39291 39307 39585
    Long Term Investments 1290 1143 1234 1142 1102
    Note Receivable - Long Term 761 752 682 835 792
    Other Long Term Assets, Total 4208 3899 3614 3337 3548
    Total Current Liabilities 28588 26375 24860 26293 24850
    Payable/Accrued 20542 19738 19210 19040 17694
    Notes Payable/Short Term Debt 331 271 568 261 584
    Current Port. of LT Debt/Capital Leases 5276 4516 3289 5281 5034
    Other Current Liabilities, Total 2439 1850 1793 1711 1538
    Total Liabilities 58889 59151 60898 59446 59051
    Total Long Term Debt 22969 25051 27646 23690 23681
    Long Term Debt 22225 24329 26916 22965 23013
    Capital Lease Obligations 744 722 730 725 668
    Deferred Income Tax 2752 2800 2795 2944 3479
    Minority Interest 24 24 22 21 20
    Other Liabilities, Total 4556 4901 5575 6498 7021
    Total Equity 37197 37392 35789 37037 35134
    Common Stock 387 387 387 387 387
    Additional Paid-In Capital 35166 35163 35159 35155 35137
    Retained Earnings (Accumulated Deficit) 1644 1842 243 1495 -390
    Total Liabilities & Shareholders’ Equity 96086 96543 96687 96483 94185
    Total Common Shares Outstanding 1549.91 1549.88 1549.85 1549.8 1549.51
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 2501 -265 3916 1548 1993
    Cash From Operating Activities 9808 5963 4799 2969 2618
    Cash From Operating Activities 5480 6530 3149 3762 3753
    Non-Cash Items 542 141 -332 -103 -1276
    Cash Taxes Paid 1623 1743 1562 1118 537
    Cash Interest Paid 849 721 733 774 676
    Changes in Working Capital 1285 -443 -1934 -2238 -1852
    Cash From Investing Activities -2960 -11058 -285 -657 963
    Capital Expenditures -2571 -2200 -2606 -2460 -1371
    Other Investing Cash Flow Items, Total -389 -8858 2321 1803 2334
    Cash From Financing Activities -6823 3649 -2203 -1765 -2044
    Financing Cash Flow Items -1047 -178 -101 4 -67
    Total Cash Dividends Paid -4364 -3856 -3572 -3592 -3484
    Issuance (Retirement) of Stock, Net 29 29 30 3525 34
    Issuance (Retirement) of Debt, Net -1441 7654 1440 -1702 1473
    Foreign Exchange Effects -80 -62 12 5 -38
    Net Change in Cash -55 -1508 2323 552 1499
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 2262 2501 1723 800 553
    Cash From Operating Activities 3133 9808 7410 4480 3232
    Cash From Operating Activities 1502 5480 4000 2666 1309
    Non-Cash Items -391 542 172 15 -12
    Cash Taxes Paid 225 1623 1335 1006 228
    Cash Interest Paid 257 849 608 386 194
    Changes in Working Capital -240 1285 1515 999 1382
    Cash From Investing Activities -1246 -2960 -2711 -968 -168
    Capital Expenditures -1470 -2571 -2017 -906 -363
    Other Investing Cash Flow Items, Total 224 -389 -694 -62 195
    Cash From Financing Activities -2031 -6823 -6465 -5035 -3740
    Financing Cash Flow Items -840 -1047 -1047 -997 -997
    Total Cash Dividends Paid -3047 -4364 -4364 -2971 -2971
    Issuance (Retirement) of Stock, Net 4 29 11 8 5
    Issuance (Retirement) of Debt, Net 1852 -1441 -1065 -1075 223
    Foreign Exchange Effects -11 -80 -86 -35 -9
    Net Change in Cash -155 -55 -1852 -1558 -685
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5096 100893184 1200 2023-01-31 LOW
    Wellington Management Company, LLP Investment Advisor/Hedge Fund 4.1998 65092368 768 2023-01-31 LOW
    Investor AB Private Equity 3.3298 51608948 608 2023-01-31 LOW
    Capital Research Global Investors Investment Advisor 3.1211 48374655 -165706 2023-06-15 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.8719 44511608 671315 2023-06-15 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 2.2154 34336042 875 2023-10-01 LOW
    Capital World Investors Investment Advisor 1.8709 28997204 474010 2023-06-15 LOW
    BlackRock Investment Management (UK) Ltd. Investment Advisor/Hedge Fund 1.3307 20624979 125455 2023-10-01 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 1.1707 18144143 -35319 2023-10-01 LOW
    GQG Partners, LLC Investment Advisor 1.0711 16600615 66511 2023-06-15 MED
    Legal & General Investment Management Ltd. Investment Advisor/Hedge Fund 0.9319 14443159 -63166 2023-10-01 LOW
    State Street Global Advisors (UK) Ltd. Investment Advisor/Hedge Fund 0.7607 11789511 0 2023-10-01 LOW
    Fidelity Management & Research Company LLC Investment Advisor 0.6104 9460420 45825 2023-10-01 LOW
    Nuveen LLC Pension Fund 0.5685 8811257 378713 2023-06-15 LOW
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5618 8707369 257289 2023-06-15 LOW
    Aviva Investors Global Services Limited Investment Advisor/Hedge Fund 0.5266 8162319 -429899 2023-10-01 LOW
    Handelsbanken Kapitalförvaltning AB Investment Advisor/Hedge Fund 0.5212 8078066 1670 2023-09-30 LOW
    M&G Investment Management Ltd. Investment Advisor 0.4752 7364510 948 2023-10-01 LOW
    State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.4611 7146065 10590 2023-10-01 LOW
    Union Investment Privatfonds GmbH Investment Advisor 0.4173 6467102 30000 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    AstraZeneca - SEK Company profile

    AstraZeneca is a multinational biopharmaceutical company that resulted from the merger between the Swedish Astra AB and the English Zeneca Group in 1999. The company is engaged in developing and manufacturing products to treat oncology, cardiovascular & metabolic disease (CVMD) and pursues therapies in autoimmunity, infection and neuroscience. Its R&D headquarters are located in Warsaw, Poland, while its corporate base is in London, England. AstraZeneca is listed on the stock exchanges in London, New York and Stockholm under the ticker AZN. The AZN stock belongs to the FTSE 100 Index. Follow the latest developments of the AstraZeneca share price at Capital.com.
    Industry: Pharmaceuticals (NEC)

    1 Francis Crick Avenue
    CAMBRIDGE
    CAMBRIDGESHIRE CB2 0AA
    GB

    Income Statement

    • Annual
    • Quarterly

    News

    December RBA preview: no move expected at the final meeting of 2023

    The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

    14:47, 4 December 2023

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

    12:39, 30 November 2023

    Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

    EZ PI expected to drop further but speed of decline

    08:16, 29 November 2023

    A weaker Dollar drives gold higher

    Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

    13:49, 28 November 2023

    Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

    US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

    13:20, 28 November 2023

    RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

    The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

    13:04, 28 November 2023

    Crude prices slide on OPEC+ uncertainty

    Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

    12:55, 28 November 2023

    People also watch

    Oil - Crude

    71.81 Price
    +0.540% 1D Chg, %
    Long position overnight fee -0.0204%
    Short position overnight fee -0.0015%
    Overnight fee time 22:00 (UTC)
    Spread 0.040

    US100

    16,044.20 Price
    -0.200% 1D Chg, %
    Long position overnight fee -0.0262%
    Short position overnight fee 0.0040%
    Overnight fee time 22:00 (UTC)
    Spread 1.8

    XRP/USD

    0.63 Price
    -6.620% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 22:00 (UTC)
    Spread 0.01168

    BTC/USD

    42,374.25 Price
    -3.730% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 22:00 (UTC)
    Spread 106.00

    Still looking for a broker you can trust?

    Join the 570.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading